
Nita M. Minnifield
Examiner (ID: 3839, Phone: (571)272-0860 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 1813, 1802, 1817 |
| Total Applications | 1564 |
| Issued Applications | 1017 |
| Pending Applications | 126 |
| Abandoned Applications | 425 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7468110
[patent_doc_number] => 20040120966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/751702
[patent_app_country] => US
[patent_app_date] => 2004-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20509
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20040120966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10751702
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/751702 | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof | Jan 4, 2004 | Issued |
Array
(
[id] => 7502404
[patent_doc_number] => 08034378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Immunogenic compositions containing phospholipid'
[patent_app_type] => utility
[patent_app_number] => 10/748117
[patent_app_country] => US
[patent_app_date] => 2003-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16833
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10748117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/748117 | Immunogenic compositions containing phospholipid | Dec 28, 2003 | Issued |
Array
(
[id] => 7199832
[patent_doc_number] => 20040086558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Liposome mediated dna administration'
[patent_app_type] => new
[patent_app_number] => 10/468571
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5186
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086558.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468571 | Liposome mediated dna administration | Dec 22, 2003 | Abandoned |
Array
(
[id] => 7336877
[patent_doc_number] => 20040132685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Immunostimulatory nucleic acid'
[patent_app_type] => new
[patent_app_number] => 10/743625
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21901
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10743625
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/743625 | Immunostimulatory nucleic acid | Dec 21, 2003 | Abandoned |
Array
(
[id] => 82259
[patent_doc_number] => 07745606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Immunostimulatory sequence oligonucleotides and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/741720
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44562
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745606.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741720 | Immunostimulatory sequence oligonucleotides and methods of using the same | Dec 17, 2003 | Issued |
Array
(
[id] => 4493373
[patent_doc_number] => 07956043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => '5′ CpG nucleic acids and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/735592
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22169
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735592 | 5′ CpG nucleic acids and methods of use | Dec 10, 2003 | Issued |
Array
(
[id] => 5705263
[patent_doc_number] => 20060194311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Lna-cpg conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/538129
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9934
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538129
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538129 | Lna-cpg conjugates | Dec 3, 2003 | Abandoned |
Array
(
[id] => 7224024
[patent_doc_number] => 20050261215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Methods and immune modulatory nucleic acid compositions for preventing and treating disease'
[patent_app_type] => utility
[patent_app_number] => 10/524643
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27114
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261215.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524643 | Methods and immune modulatory nucleic acid compositions for preventing and treating disease | Nov 20, 2003 | Issued |
Array
(
[id] => 7183015
[patent_doc_number] => 20040203026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Biologically active bactericidal/permeability-increasing protein fragments'
[patent_app_type] => new
[patent_app_number] => 10/716389
[patent_app_country] => US
[patent_app_date] => 2003-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7446
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10716389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/716389 | Biologically active bactericidal/permeability-increasing protein fragments | Nov 17, 2003 | Abandoned |
Array
(
[id] => 7256362
[patent_doc_number] => 20050075496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Plasmodium falciparum antigens and their vaccine and diagnostic applications'
[patent_app_type] => utility
[patent_app_number] => 10/712533
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16621
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712533 | Plasmodium falciparum antigens and their vaccine and diagnostic applications | Nov 13, 2003 | Issued |
Array
(
[id] => 442079
[patent_doc_number] => 07255867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/706275
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 28
[patent_no_of_words] => 11436
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/255/07255867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706275
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706275 | Vaccine | Nov 12, 2003 | Issued |
Array
(
[id] => 7333563
[patent_doc_number] => 20040131694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutic application'
[patent_app_type] => new
[patent_app_number] => 10/697264
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7489
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10697264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/697264 | Pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutic application | Oct 30, 2003 | Abandoned |
Array
(
[id] => 4618778
[patent_doc_number] => 07998492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Methods and products related to treatment and prevention of hepatitis C virus infection'
[patent_app_type] => utility
[patent_app_number] => 10/532746
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 25924
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532746
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532746 | Methods and products related to treatment and prevention of hepatitis C virus infection | Oct 28, 2003 | Issued |
Array
(
[id] => 4570886
[patent_doc_number] => 07824696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'
[patent_app_type] => utility
[patent_app_number] => 10/694418
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 56
[patent_no_of_words] => 9059
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10694418
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/694418 | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes | Oct 26, 2003 | Issued |
Array
(
[id] => 7467979
[patent_doc_number] => 20040198951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/680349
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12530
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10680349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/680349 | Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof | Oct 6, 2003 | Abandoned |
Array
(
[id] => 7308776
[patent_doc_number] => 20040142399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Recombinant FlaA as a diagnostic reagent'
[patent_app_type] => new
[patent_app_number] => 10/675447
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6790
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675447 | Recombinant FlaA as a diagnostic reagent | Sep 29, 2003 | Abandoned |
Array
(
[id] => 623164
[patent_doc_number] => 07138115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/659586
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6515
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10659586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/659586 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases | Sep 10, 2003 | Issued |
Array
(
[id] => 7150799
[patent_doc_number] => 20040171525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Method of using lectins for prevention and treatment of oral and alimentary tract disorders'
[patent_app_type] => new
[patent_app_number] => 10/654104
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7657
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10654104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/654104 | Method of using lectins for prevention and treatment of oral and alimentary tract disorders | Sep 2, 2003 | Abandoned |
Array
(
[id] => 6966051
[patent_doc_number] => 20050232948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Adjuvanted vaccine which is substantially free of non-host albumin'
[patent_app_type] => utility
[patent_app_number] => 10/654534
[patent_app_country] => US
[patent_app_date] => 2003-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9048
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10654534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/654534 | Process for making an adjuvanted vaccine comprising host albumin | Sep 1, 2003 | Issued |
Array
(
[id] => 545034
[patent_doc_number] => 07166708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-23
[patent_title] => 'Process for preparing conjugate vaccines and the conjugate vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/650786
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7295
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/166/07166708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10650786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/650786 | Process for preparing conjugate vaccines and the conjugate vaccines | Aug 28, 2003 | Issued |